Patterns and perceptions of complementary and alternative medicine (CAM) among leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital
- 1 November 2002
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 11 (8) , 671-676
- https://doi.org/10.1002/pds.782
Abstract
Purpose: The use of complementary and alternative medicine (CAM) in cancer treatments is widespread with substantial number of patients deserting conventional cancer therapies in favour of unproven methods. The present study aimed at discovering the prevalence of use of CAM cancer therapies in leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital.Methods: 533 consecutive leukaemia patients were interviewed. Information was gathered about patients' demographics, types of CAM taken, sequence of seeking CAM and conventional medicine, sources of recommendation, reasons of opting for CAM, and areas of satisfaction and dissatisfaction associated with the use of CAM. Patients were also asked if they had informed their doctor about CAM use.Results: Prevalence of CAM use in leukaemia patients was found to be 56.6%. Ayurveda was the most commonly used CAM (33%). Most of the patients sought conventional medicine first, followed by CAM therapies. Fifty‐two percent of the patients opted for CAM hoping for a miracle cure and 51% were dissatisfied with these therapies. Family members and neighbours constituted major source of recommendation of CAM therapy. Only 3.8% of the patients had informed their doctors about CAM use.Conclusion: A sizeable percentage of patients receiving conventional treatment for leukaemia also use CAM therapies. Clinicians should not underestimate the value of hopeful attitude in their management of leukaemia patients and ought to be conversant with popular forms of CAM cancer therapies. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 17 references indexed in Scilit:
- Use of micronutrients and alternative drugs by children with acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1997
- Pursuit and practice of complementary therapies by cancer patients receiving conventional treatmentBMJ, 1994
- Medicine in Europe: Complementary medicine in EuropeBMJ, 1994
- Therapeutic landscapes: Medical issues in light of the new cultural geographySocial Science & Medicine, 1992
- Survival and Quality of Life among Patients Receiving Unproven as Compared with Conventional Cancer TherapyNew England Journal of Medicine, 1991
- Bristol Cancer Help CentreThe Lancet, 1990
- High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior ChemotherapyNew England Journal of Medicine, 1985
- Sensory Neuropathy from Pyridoxine AbuseNew England Journal of Medicine, 1983
- After Laetrile, What?New England Journal of Medicine, 1982
- A Clinical Trial of Amygdalin (Laetrile) in the Treatment of Human CancerNew England Journal of Medicine, 1982